Skip to Content
Return to Navigation

Moderna’s Coronavirus Vaccine Shows Encouraging Early Results in Human Safety Trial-The Washington Post, 5/18

Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results from its first human safety tests Monday. The company plans to launch a large clinical trial in July aimed at showing whether the vaccine works. The Washington Post, 05/18/2020

Share this article: